Keyword: Pharmaceuticals

News

Biogen Wins EU Backing for Big New MS Drug Hope

22.03.2013 - European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...

News

Antibiotics Crisis Prompts Rethink on Risks, Rewards

18.03.2013 - Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...

News

GlaxoSmithKline Boss Says New Drugs Can Be Cheaper

14.03.2013 - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief...

News

Elan to Start Share Buyback Next Week

10.03.2013 - Drugmaker Elan is to bring forward a planned $1 billion share buyback to next week, the Irish company said in a statement, a move that could undermine a takeover offer by U.S...

News

Merck KGaA's Profit Up on Cost Cuts, Liquid Crystals

07.03.2013 - German drugs and chemicals maker Merck KGaA surpassed expectations for quarterly earnings, helped by job cuts and strong demand from China for its liquid crystals for televisions...

News

DSM Signs Master Supply Agreement with Eisai

06.03.2013 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, today announced the signing of a 3 year master supply agreement with Eisai, based in...

News

Pfizer Gets Celebrex Patent Extension

05.03.2013 - U.S. regulators granted Pfizer a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on...

News

Par to Pay $45 Million, End US Probes Over AIDS Appetite Drug

05.03.2013 - Par Pharmaceutical has agreed to pay $45 million to settle federal criminal and civil probes over its marketing and sale of a drug to treat appetite loss in AIDS patients, a...